Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Views
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE

Freeze Dryer

By Drug Discovery Trends Editor | October 26, 2009

LyoStarSP Industries Inc., a leader in laboratory, pilot, and production freeze dryers, has announced that it will exhibit its latest innovative products at the 2009 American Association for Pharmaceutical Scientists (AAPS) meeting in Los Angeles, CA (November 8-12th).

Center stage on Booth 1229 at AAPS 2009 – SP Industries will be demonstrating its latest introduction – the LyoStar Freeze Dryer with SMART freeze dryer technology.  Pharmaceutical scientists will be able to see how integrating the new generation LyoStar Freeze Dryer with SP Industries’ exclusive SMART freeze dryer technology provides development scientists with maximum programming flexibility and product protection whether the product is processed in vials, bulk trays, 96 well plates, or syringes. 

LyoStar represents the pinnacle of freeze dryer engineering. Designed and built like a production freeze drier, yet the size of a pilot plant model. The LyoStar has everything that you would expect, superior shelf mapping, fast shelf freezing, stoppering for vials, ease of use, high reliability and incredible software which drastically reduces the average formulation development cycle time.

SMART freeze dryer technology is a patented system that puts the experience of the world’s top lyophilisation scientists into an easy-to-use cycle development tool.  SMART freeze dryer technology enables development scientists to create a streamlined but safe process that can shave days off the production cycle. This efficiency gain can eliminate production bottlenecks, expand capacity and reduce production costs.

SP Industries

 


Filed Under: Drug Discovery

 

Related Articles Read More >

TransCelerate CEO Janice Chang wants trials to become part of routine care
STEERLife’s FragMelt platform manufactures drugs with heat sensitive active ingredient 
S&P report highlights Big Pharma’s concentration risk amid pre-JPM deal flurry
Eli Lilly in the Drug Discovery & Development Pharma 50
Lilly Phase 3b trial shows roughly 40-fold higher combined arthritis and weight-loss response
“ddd
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in the drug discovery and development industry.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medtech100 Index
  • Medical Design Sourcing
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2026 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Views
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE